Pfizer, Roche, Aspen Accused of Overcharging for Cancer Drugs

Jun 13, 2017

Reuters

South Africa's Competition Commission announced an investigation into three drug companies accused of over-charging for cancer medicines, according to a Reuters article.

Tembinkosi Bonakele, head of the Commission, said they would investigate Aspen Pharmacare, Africa's biggest generic drug manufacturer; New York-based Pfizer; and Swiss company Roche Holding.

The Commission investigates cases before bringing them to the Competition Tribunal for adjudication.

Read the full story

Show Comments
Hide Comments

Join the discussion

We welcome your thoughtful comments.
All comments will display your user name.

Want to participate in the discussion?

Register for free

Log in for complete access.

Comments

No one has commented on this page yet.

RSS feed for comments on this page | RSS feed for all comments